Andrew Obenshain Bluebird Bio, Inc. (BLUE) insider trading activity

Andrew Obenshain is President and CEO of bluebird bio, Inc.. Currently has a direct ownership of 375,218 shares of BLUE, which is worth approximately $157,591. The most recent transaction as insider was on Sep 30, 2024, when has been sold 34,780 shares (Common Stock) at a price of $0.53 per share, resulting in proceeds of $18,433. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 375K

34.01% 3M change

28.88% 12M change

Total Value Held $157,591

Andrew Obenshain Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	SELL Open market or private sale	$18,433 $0.53 p/Share	34,780 Reduced 8.48%	375,218 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	130,000 Added 24.07%	409,998 Common Stock
Mar 04 2024	SELL Open market or private sale	$9,325 $1.53 p/Share	6,095 Reduced 2.13%	279,998 Common Stock
Feb 05 2024	SELL Open market or private sale	$1,691 $0.9 p/Share	1,879 Reduced 0.65%	286,093 Common Stock
Jan 05 2024	SELL Open market or private sale	$4,521 $1.43 p/Share	3,162 Reduced 1.09%	287,972 Common Stock
Nov 03 2023	SELL Open market or private sale	$2,558 $3.17 p/Share	807 Reduced 0.28%	291,134 Common Stock
Aug 10 2023	SELL Open market or private sale	$59,928 $3.54 p/Share	16,929 Reduced 5.48%	291,941 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	67,600 Added 17.96%	308,870 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$9,059 $6.38 p/Share	1,420 Reduced 0.59%	241,270 Common Stock
Jan 11 2023	SELL Open market or private sale	$24,788 $7.8 p/Share	3,178 Reduced 1.29%	242,690 Common Stock
Nov 04 2022	SELL Open market or private sale	$8,095 $6.41 p/Share	1,263 Reduced 0.51%	245,868 Common Stock
Aug 04 2022	SELL Open market or private sale	$95,724 $4.39 p/Share	21,805 Reduced 8.11%	247,131 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	18,000 Added 6.27%	268,936 Common Stock
Jan 11 2022	SELL Open market or private sale	$45,144 $9.64 p/Share	4,683 Reduced 1.86%	246,696 Common Stock
Jan 10 2022	SELL Open market or private sale	$28,351 $9.32 p/Share	3,042 Reduced 1.2%	251,379 Common Stock
Dec 07 2021	SELL Open market or private sale	$8,470 $10.18 p/Share	832 Reduced 0.33%	254,421 Common Stock
Nov 11 2021	BUY Other acquisition or disposition	-	245,371 Added 49.01%	255,253 Common Stock
Aug 02 2021	BUY Grant, award, or other acquisition	-	100,000 Added 41.74%	139,597 Common Stock
Jun 04 2021	SELL Open market or private sale	$15,713 $30.75 p/Share	511 Reduced 1.27%	39,597 Common Stock
May 03 2021	SELL Open market or private sale	$874 $30.15 p/Share	29 Reduced 0.07%	40,108 Common Stock
Apr 05 2021	SELL Open market or private sale	$876 $30.21 p/Share	29 Reduced 0.07%	40,137 Common Stock
Mar 02 2021	SELL Open market or private sale	$1,006 $29.58 p/Share	34 Reduced 0.08%	40,166 Common Stock
Feb 17 2021	SELL Open market or private sale	$21,092 $28.16 p/Share	749 Reduced 1.83%	40,200 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	17,065 Added 29.42%	40,949 Common Stock
Feb 02 2021	SELL Open market or private sale	$1,562 $45.93 p/Share	34 Reduced 0.14%	23,884 Common Stock

Andrew Obenshain

President and CEO

Somerville, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Value

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

Operation

Value

Type

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE

Account